Loading: 100%
Regeneron logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Tarrytown, United States of AmericaTarrytown, United States of Americano data available
Employees 5,400 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker REGNno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17300360420480540
datesClosing price (adj.)
13.10.2017442.96
11.10.2017452.97
04.10.2017456.05
27.09.2017435.43
20.09.2017438.17
13.09.2017437.74
06.09.2017500.22
30.08.2017487.12
23.08.2017477.15
16.08.2017468.54
09.08.2017474.09
02.08.2017476.82
26.07.2017515.63
19.07.2017506.79
12.07.2017496.99
05.07.2017497.00
27.06.2017502.12
20.06.2017495.33
13.06.2017473.67
06.06.2017477.73
30.05.2017448.67
23.05.2017461.37
16.05.2017454.75
09.05.2017427.18
02.05.2017402.04
25.04.2017372.43
18.04.2017366.06
11.04.2017367.07
04.04.2017382.92
28.03.2017382.55
21.03.2017370.98
14.03.2017391.10
07.03.2017372.52
28.02.2017373.50
21.02.2017371.61
14.02.2017376.52
07.02.2017357.69
31.01.2017359.29
24.01.2017347.96
17.01.2017363.24
10.01.2017373.00
03.01.2017379.70
27.12.2016385.95
19.12.2016371.75
12.12.2016387.10
05.12.2016369.82
28.11.2016390.38
21.11.2016405.48
14.11.2016444.52
07.11.2016365.39
31.10.2016345.02
24.10.2016362.25
17.10.2016366.73
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
442.96n/a
Market Capitalisation
in million USD
47,082n/a
Enterprise Value
in million USD
47,270n/a
Common Shares Outstanding
as per Apr 13, 2017
106,290,608n/a
Preferred Shares Outstanding
as per Apr 13, 2017
n/a
Average Basic Shares Outstanding
TTM
105,039,500n/a
Average Diluted Shares Outstanding
TTM
116,586,500n/a
Index Membership
n/a
Business Summary
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 4,860n/a
Gross Profit 4,561n/a
Operating Income 1,331n/a
EBITDA 1,435n/a
Net Profit 896n/a
Balance Sheet
Cash and Cash Equivalents 263n/a
Receivables 507n/a
Total Current Assets 949n/a
PP&E 373n/a
Total Assets 1,661n/a
Accounts Payable 124n/a
Current Debt 0n/a
Total Current Liabilities 179n/a
Long-Term Debt 450n/a
Total Liabilities 855n/a
Total Equity 806n/a
Cash Flow
Depreciation & Amortisation 105n/a
Change in Working Capital 228n/a
Operating Cash Flow 1,473n/a
Net Change in PP&E and Intangibles -512n/a
Investing Cash Flow -1,047n/a
Dividends Paid 0n/a
Financing Cash Flow -700n/a
Total Change in Cash -274n/a
Free Cash Flow 717n/a
Profitability Ratios
Gross Margin 93.8%n/a
Operating Margin 27.4%n/a
Net Profit Margin 18.4%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.02n/a
Other Ratios
Current Ratio 531.2%n/a
Liabilities to Equity Ratio 106.0%n/a
Debt to Assets Ratio 27.1%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
238
379
459
446
1,378
2,105
2,820
4,104
4,860
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-1
-2
-2
-4
-84
-155
-205
-393
-300
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
238
378
457
442
1,294
1,949
2,615
3,711
4,561
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-324
-452
-554
-647
-836
-1,206
-1,791
-2,459
-3,230
Selling, General & Administrative
-49
-53
-65
-117
-211
-346
-519
-839
-1,178
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-275
-399
-489
-530
-626
-860
-1,271
-1,621
-2,052
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
-86
-74
-97
-205
458
743
824
1,252
1,331
Non-Operating Income (Loss)
9
2
-7
-18
-43
-47
-63
-27
-1
Interest Expense, net
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
9
2
-7
-18
-43
-47
-63
-27
-1
Pretax Income (Loss), Adjusted
-77
-72
-104
-223
414
696
761
1,225
1,330
Abnormal Gains (Losses)
0
0
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-77
-72
-104
-223
414
696
761
1,225
1,330
Income Tax (Expense) Benefit, net
-2
4
0
1
336
-283
-423
-589
-434
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-79
-68
-104
-222
750
414
338
636
896
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-79
-68
-104
-222
750
414
338
636
896
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
-79
-68
-104
-222
750
414
338
636
896
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-79
-68
-104
-222
750
414
338
636
896
Remarks
restated on Feb 17, 2011 n/a
calculated values,
restated on Feb 21, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 13, 2014 n/a
calculated values,
restated on Feb 12, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
Balance SheetBS data quality: 66% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
341
249
527
308
694
900
1,045
1,039
Cash & Cash Equivalents
n/a
207
113
484
230
536
649
809
535
Short Term Investments
n/a
134
137
43
78
158
252
236
503
Accounts & Notes Receivable
n/a
3
2
28
593
787
739
1,152
1,343
Accounts Receivable, Net
n/a
3
2
28
593
787
739
1,152
1,343
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
29
70
129
239
399
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
81
106
111
276
246
316
479
399
Prepaid Expenses
n/a
19
26
36
28
33
79
164
131
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
148
45
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
63
80
75
100
168
237
315
268
Total Current Assets
n/a
426
358
666
1,206
1,797
2,085
2,915
3,180
Property, Plant & Equipment, Net
n/a
260
347
368
380
527
974
1,594
2,083
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
47
370
276
271
390
460
632
864
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
9
14
14
223
237
318
468
846
Intangible Assets
n/a
0
0
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
192
232
315
462
825
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
9
14
14
31
5
3
6
20
Total Noncurrent Assets
n/a
316
732
658
874
1,154
1,753
2,694
3,793
Total Assets
n/a
741
1,089
1,324
2,080
2,951
3,838
5,609
6,973
Liabilities and owners' equity
Payables & Accruals
n/a
49 49031000
54 53658000
96 95625000
111 111345000
251 250896000
483 483489000
644 644112000
879 879096000
Accounts Payable
n/a
49 49031000
54 53658000
96 95625000
111 111345000
251 250896000
483 483489000
644 644112000
879 879096000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
127 127274000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
45 44544000
55 55398000
53 52646000
52 52205000
48 47939000
171 171171000
167 167050000
235 235125000
Deferred Revenue
n/a
45 44544000
55 54723000
52 51640000
51 50831000
47 47000000
74 74025000
153 153487000
232 231664000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
1 675000
1 1006000
1 1374000
1 939000
97 97146000
14 13563000
3 3461000
Total Current Liabilities
n/a
94 93575000
109 109056000
148 148271000
164 163550000
299 298835000
655 654660000
811 811162000
1,241 1241495000
Long Term Debt
n/a
109 109022000
159 159355000
435 434527000
456 455954000
505 504573000
458 457711000
363 362919000
352 351569000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
142 141843000
293 293206000
255 255053000
216 215601000
196 195529000
175 175050000
780 780214000
931 931157000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
91 90933000
97 97081000
86 86017000
77 76520000
77 76522000
63 62819000
583 582664000
503 503474000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
51 50910000
196 196125000
169 169036000
139 139081000
119 119007000
112 112231000
198 197550000
428 427683000
Total Noncurrent Liabilities
n/a
251 250865000
453 452561000
690 689580000
672 671555000
700 700102000
633 632761000
1,143 1143133000
1,283 1282726000
Total Liabilities
n/a
344 344440000
562 561617000
838 837851000
835 835105000
999 998937000
1,287 1287421000
1,954 1954295000
2,524 2524221000
Preferred Equity
n/a
0 2000
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
1,337 1336811000
1,576 1575867000
1,755 1754824000
1,764 1763508000
2,046 2045857000
2,451 2450782000
3,100 3099526000
3,030 3029993000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
-170 -169530000
-306 -306069000
-316 -316240000
Retained Earnings
n/a
-941 -941095000
-1,046 -1045563000
-1,267 -1267323000
-517 -517054000
-93 -92692000
217 216644000
853 852700000
1,748 1748222000
Other Equity
n/a
1 1044000
-2 -2491000
-2 -1862000
-1 -1166000
-1 -1188000
52 52251000
9 8572000
-13 -12840000
Equity Before Minority Interest
n/a
397 396762000
528 527813000
486 485639000
1,245 1245288000
1,952 1951977000
2,550 2550147000
3,655 3654729000
4,449 4449135000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
397 396762000
528 527813000
486 485639000
1,245 1245288000
1,952 1951977000
2,550 2550147000
3,655 3654729000
4,449 4449135000
Total Liabilities & Equity
n/a
741 741202000
1,089 1089430000
1,323 1323490000
2,080 2080393000
2,951 2950914000
3,838 3837568000
5,609 5609024000
6,973 6973356000
Remarks restated on n/a restated on Feb 17, 2011 n/a restated on Feb 21, 2012 n/a restated on Feb 15, 2013 n/a restated on Feb 13, 2014 n/a restated on Feb 12, 2015 n/a restated on Feb 11, 2016 n/a restated on Feb 9, 2017 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-79
-68
-104
-222
750
414
338
636
896
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
11
14
20
31
37
41
53
75
105
Non-Cash Items
35
33
44
68
-189
324
346
390
245
Stock-Based Compensation
33
31
40
56
94
215
322
459
560
Deferred Income Taxes
0
0
0
0
-340
62
-53
-122
-360
Other Non-Cash Adjustments
2
2
4
12
57
47
78
53
45
Change in Working Capital
-56
-50
140
-19
-673
-191
16
230
228
(Increase) Decrease in Accounts Receivable
-17
-30
-18
-21
-588
-245
-35
-491
-144
(Increase) Decrease in Inventories
0
0
0
-14
-29
-48
-57
-112
-150
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
-39
-19
158
16
-55
103
107
833
522
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
-89
-70
99
-142
-75
589
752
1,331
1,473
Change in Fixed Assets & Intangibles
-35
-97
-100
-57
-49
-156
-333
-678
-512
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
-35
-97
-100
-57
-49
-156
-333
-678
-512
Net Change in Long Term Investment
66
95
-331
186
-32
-199
-88
-230
-535
Decrease in Long Term Investment
647
295
274
426
439
378
476
327
274
Increase in Long Term Investment
-581
-200
-605
-240
-471
-577
-564
-557
-809
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
-6
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
31
-2
-437
128
-81
-355
-421
-908
-1,047
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-201
23
47
389
-2
-2
-222
-140
-41
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
8
9
201
44
64
57
126
206
127
Increase in Capital Stock
8
9
201
44
64
57
126
206
127
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
0
0
-4
-49
-159
17
-123
-329
-787
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-193
31
243
384
-98
72
-219
-263
-700
Net Cash Before Disc. Operations and FX
-251
-41
-95
371
-253
305
113
160
-274
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-251
-41
-95
371
-253
305
113
160
-274
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
Net Changes in Cash
-251
-41
-95
371
-253
305
113
160
-274
Remarks
restated on Feb 17, 2011 n/a
calculated values,
restated on Feb 21, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 13, 2014 n/a
calculated values,
restated on Feb 12, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo